ImportantUpdates
AstraZeneca's Board has proposed a final dividend of Rs. 36 per share for FY25-26, pending shareholder approval.
AstraZeneca Pharma India LimitedASTRAZEN · Filed with the exchange
Tax will be deducted at source on this dividend, with rates varying based on shareholder residential status and documentation.
Shareholders are advised to update their details by July 31 for accurate tax withholding.
No comments yet. Be the first.